CD274 and neoplasm: In response to low levels of T-cell infiltration and insufficient inhibitor binding to PD-L1 in the immunosuppressive tumor microenvironment (TME), a novel PEC nanosystem—a hybrid structure composed of E. coli and tumor cell membranes—was developed to enable selective delivery of PD-L1 inhibitors directly to the tumor.